- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 6, 2024 | 9.25M sh |
| Short Term Investments | Q3 2024 · Mar 31, 2024 | $7.02M |
| Short Term Investments | Q3 2024 · Jun 30, 2023 | $17.06M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $2.91M |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $3.09M |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $1.65M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $2.38M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $6.48M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $7.28M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $17.24M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $29.1M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $37.6M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $39.09M |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 9.21M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 9.79M sh |
| Capex | Q3 2024 · Mar 31, 2023 | $68.24K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | $10.62M |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2023 | $31.99M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | $32.09M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2022 | $23.03M |
| Eps Diluted restated | Q3 2024 · Mar 31, 2023 | −$0.02 |
| Eps Diluted restated | Q3 2024 · Mar 31, 2023 | $0.88 |
| Eps Basic restated | Q3 2024 · Mar 31, 2023 | −$0.02 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.93 |
| Sga Expense restated | Q3 2024 · Mar 31, 2023 | $1.75M |
| Sga Expense restated | Q3 2024 · Mar 31, 2023 | $27.91M |
| Net Income restated | Q3 2024 · Mar 31, 2023 | −$224.48K |
| Net Income restated | Q3 2024 · Mar 31, 2023 | $8.58M |
| Operating Income restated | Q3 2024 · Mar 31, 2023 | −$444.98K |
| Operating Income restated | Q3 2024 · Mar 31, 2023 | −$24.27M |
| Gross Profit restated | Q3 2024 · Mar 31, 2023 | $1.3M |
| Gross Profit restated | Q3 2024 · Mar 31, 2023 | $3.64M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $2.08M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $6.39M |